Detalhe da pesquisa
1.
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern.
PLoS Pathog
; 18(10): e1010882, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36191037
2.
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Clin Infect Dis
; 76(2): 201-209, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36196614
3.
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction-associated fatty liver disease(MAFLD) in adults with suppressed HIV.
AIDS
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819839
4.
Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection.
mBio
; 14(5): e0120623, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37747187
5.
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants.
Cell Rep
; 39(5): 110757, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477023
6.
Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption.
Front Immunol
; 13: 878743, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36110857
7.
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.
JCI Insight
; 7(7)2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192543
8.
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.
Nat Med
; 8(4): 379-85, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11927944
9.
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
Lancet HIV
; 8(8): e474-e485, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153264
10.
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection.
PLoS Biol
; 2(2): E20, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14966528
11.
Complete mapping of a novel HLA A*6801-restricted HIV-1 Tat epitope directly with a rapid modified enzyme-linked immunospot assay.
AIDS
; 16(9): 1285-7, 2002 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-12045495
12.
Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects.
AIDS
; 17(16): 2299-311, 2003 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-14571181
13.
The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml.
AIDS
; 16(11): 1521-7, 2002 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-12131190
14.
Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapy.
J Infect Dis
; 195(3): 410-5, 2007 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17205480
15.
Intracellular cytokines may model immunoregulation of abacavir hypersensitivity in HIV-infected subjects.
J Allergy Clin Immunol
; 115(5): 1081-7, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15867870
16.
Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection.
J Immunol
; 169(11): 6376-85, 2002 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12444145
17.
Characterization of CD4(+) CTLs ex vivo.
J Immunol
; 168(11): 5954-8, 2002 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12023402
18.
Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
J Infect Dis
; 190(4): 713-21, 2004 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15272399